Perspectives

Henry Schvey, professor emeritus and former chair of the Performing Arts Department in Arts & Sciences, remembers celebrated actress and longtime friend to the department Jane Lapotaire.

Announcing “major combat operations,” President Trump called on the Iranian people to rise against their government. Now, he declared, would be their “only chance for generations.” This appeal to opportunity echoes arguments for the Liberator’s Civil War of 43-42 BC, which pitted Roman republican Markus Junius Brutus against future emperor Octavius, writes Krister Knapp.

In 10 months, when Branson’s theaters close up shop for the season and the receipts are calculated, it will be interesting to see whether going all in on faith, family and flag was worth it, writes Joanna Dee Das.

Unless Colorado makes the Family Affordability Tax Credit a permanent and reliable fixture of the state budget – as a recent proposal aims to do – the progress the state has made in reducing child poverty may only be temporary, writes Stephen Roll.

In this live conversation, Kate Bowler talks with sociologist Mark Rank (the Herbert S. Hadley Professor of Social Welfare), author of The Random Factor, about the role of chance in our lives. From the lottery of birth to the timing of a missed phone call, Mark’s research shows how much of what we call success—or failure—comes down to forces we never chose.

Produced in collaboration with the Frick Initiative at WashU, the series explores how freedoms of speech, religion and the press work and why they’re so often misunderstood.

If greenhouse gas emissions continue at a high rate, humanity may look back at 2025 as one the coolest years globally in the rest of our lives, writes Michael Wysession.

We and others working on eliminating these neglected diseases are concerned that the rapid decrease in funding for these programs will destabilize efforts to treat infections, write Sarah Greene and

If additional trials confirm that they effectively curb cravings across addictive substances, these drugs could begin to close one of the most consequential treatment gaps in medicine, writes Ziyad Al-Aly.

The Legislature should ignore the high-priced lobbyists and pass a law that actually protects us from data-hungry business practices that benefit no one but big tech, writes Neil Richards.